BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 175 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,710,524 | -18.4% | 53,973 | +2.7% | 0.66% | -14.3% |
Q2 2023 | $3,320,528 | +37.7% | 52,540 | -2.0% | 0.78% | +32.3% |
Q1 2023 | $2,411,329 | +167.3% | 53,597 | +160.3% | 0.59% | +154.8% |
Q4 2022 | $901,960 | -61.3% | 20,588 | -41.9% | 0.23% | -63.2% |
Q3 2022 | $2,333,000 | +28.5% | 35,406 | -1.5% | 0.62% | +25.5% |
Q2 2022 | $1,816,000 | -3.8% | 35,945 | +21.7% | 0.50% | +11.2% |
Q1 2022 | $1,887,000 | -40.8% | 29,543 | -0.8% | 0.45% | -36.9% |
Q4 2021 | $3,189,000 | +14.1% | 29,774 | +9.5% | 0.71% | +5.5% |
Q3 2021 | $2,796,000 | +15.7% | 27,196 | -1.0% | 0.67% | +14.5% |
Q2 2021 | $2,416,000 | -8.7% | 27,463 | +0.9% | 0.59% | -19.3% |
Q1 2021 | $2,645,000 | -8.0% | 27,208 | +6.1% | 0.73% | -16.6% |
Q4 2020 | $2,876,000 | +11.2% | 25,646 | -8.1% | 0.87% | +1.3% |
Q3 2020 | $2,587,000 | +22.6% | 27,907 | +3.2% | 0.86% | +13.9% |
Q2 2020 | $2,110,000 | +55.9% | 27,052 | +16.9% | 0.76% | +17.7% |
Q1 2020 | $1,353,000 | -31.2% | 23,140 | -5.8% | 0.64% | +15.2% |
Q4 2019 | $1,968,000 | +10.8% | 24,566 | +1.6% | 0.56% | +5.9% |
Q3 2019 | $1,776,000 | -25.1% | 24,178 | -3.8% | 0.53% | -19.0% |
Q2 2019 | $2,371,000 | +15.9% | 25,134 | -1.7% | 0.65% | +16.4% |
Q1 2019 | $2,046,000 | +49.2% | 25,558 | +0.5% | 0.56% | +15.0% |
Q4 2018 | $1,371,000 | -30.8% | 25,438 | +0.3% | 0.49% | -8.6% |
Q3 2018 | $1,980,000 | +49.5% | 25,362 | +21.6% | 0.53% | +40.6% |
Q2 2018 | $1,324,000 | -16.3% | 20,850 | +20.9% | 0.38% | -23.3% |
Q1 2018 | $1,581,000 | -15.7% | 17,241 | -30.7% | 0.49% | 0.0% |
Q4 2017 | $1,876,000 | -8.2% | 24,882 | -15.2% | 0.49% | -11.2% |
Q3 2017 | $2,044,000 | +16.4% | 29,335 | -15.3% | 0.56% | +14.2% |
Q2 2017 | $1,756,000 | -26.0% | 34,648 | -41.6% | 0.49% | -26.3% |
Q1 2017 | $2,374,000 | +42.1% | 59,356 | -0.4% | 0.66% | +37.7% |
Q4 2016 | $1,671,000 | +32.3% | 59,582 | +40.1% | 0.48% | +32.2% |
Q3 2016 | $1,263,000 | +45.0% | 42,520 | -1.1% | 0.36% | +36.0% |
Q2 2016 | $871,000 | +9.4% | 42,998 | -2.5% | 0.27% | +5.5% |
Q1 2016 | $796,000 | -32.3% | 44,079 | -1.2% | 0.25% | -29.7% |
Q4 2015 | $1,175,000 | +14.7% | 44,620 | -7.0% | 0.36% | +19.2% |
Q3 2015 | $1,024,000 | -19.4% | 47,974 | -0.0% | 0.30% | +3.1% |
Q2 2015 | $1,271,000 | – | 47,985 | – | 0.29% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |